Intra- and Interobserver Agreement and Impact of Arterial Input Selection in Perfusion CT Measurements Performed in Squamous Cell Carcinoma of the Upper Aerodigestive Tract

References

1. ↵
   Bisdas S, Baghi M, Smolarz A, et al. Quantitative measurements of perfusion and permeability of oropharyngeal and oral cavity cancer, recurrent disease, and associated lymph nodes using first-pass contrast-enhanced computed tomography studies. Invest Radiol 2007;42:172–79

   CrossRefPubMed
2. ↵
   Gandhi D, Hoeffner EG, Carlos RC, et al. Computed tomography perfusion of squamous cell carcinoma of the upper aerodigestive tract: initial results. J Comput Assist Tomogr 2003;27:687–93

   CrossRefPubMed
3. ↵
   Gandhi D, Chepeha DB, Miller T, et al. Correlation between initial and early follow-up CT perfusion parameters with endoscopic tumor response in patients with advanced squamous cell carcinomas of the oropharynx treated with organ-preservation therapy. AJNR Am J Neuroradiol 2006;27:101–06

   Abstract/FREE Full Text
4. ↵
   Hermans R, Meijerink M, Van den Bogaert W, et al. Tumor perfusion rate determined noninvasively by dynamic computed tomography predicts outcome in head-and-neck cancer after radiotherapy. Int J Radiat Oncol Biol Phys 2003;57:1351–56

   CrossRefPubMedWeb of Science
5. ↵
   Zima A, Carlos R, Gandhi D, et al. Can pretreatment CT perfusion predict response of advanced squamous cell carcinoma of the upper aerodigestive tract treated with induction chemotherapy? AJNR Am J Neuroradiol 2007;28:328–34

   Abstract/FREE Full Text
6. ↵
   Goh V, Halligan S, Hugill JA, et al. Quantitative assessment of colorectal cancer perfusion using MDCT: inter- and intraobserver agreement. AJR Am J Roentgenol 2005;185:225–31

   PubMed
7. ↵
   Bellomi M, Petralia G, Sonzogni A, et al. CT perfusion for the monitoring of neoadjuvant chemotherapy and radiation therapy in rectal carcinoma: initial experience. Radiology 2007;244:486–93

   CrossRefPubMed
8. ↵
   Ng QS, Goh V, Fichte H, et al. Lung cancer perfusion at multi-detector row CT: reproducibility of whole tumor quantitative measurements. Radiology 2006;239:547–53

   CrossRefPubMed
9. ↵
   Rumboldt Z, Al-Okaili R, Deveikis JP. Perfusion CT for head and neck tumors: pilot study. AJNR Am J Neuroradiol 2005;26:1178–85

   Abstract/FREE Full Text
10. ↵
    Ng QS, Goh V, Klotz E, et al. Quantitative assessment of lung cancer perfusion using MDCT: does measurement reproducibility improve with greater tumor volume coverage? AJR Am J Roentgenol 2006;187:1079–84

    CrossRefPubMed
11. ↵
    Sobin LH, Wittekind CH. TNM Classification of Malignant Tumours. 6th ed. New York: Wiley;2002
12. ↵
    Turk AS, Grayev A, Rowley HA, et al. Variability of clinical CT perfusion measurements in patients with carotid stenosis. Neuroradiology 2007;49:955–61

    CrossRefPubMed
13. ↵
    Waaijer A, van der Schaaf IC, Velthuis BK, et al. Reproducibility of quantitative CT brain perfusion measurements in patients with symptomatic unilateral carotid artery stenosis. AJNR Am J Neuroradiol 2007;28:927–32

    Abstract/FREE Full Text
14. ↵
    Lee TY, Purdie TG, Stewart E. CT imaging of angiogenesis. Q J Nucl Med 2003;47:171–87

    PubMedWeb of Science
15. ↵
    Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986;1:307–10

    CrossRefPubMedWeb of Science
16. ↵
    Bland JM, Altman DG. Measuring agreement in method comparison studies. Stat Methods Med Res 1999;8:135–60

    Abstract/FREE Full Text
17. ↵
    Rehman S, Jayson GC. Molecular imaging of antiangiogenic agents. Oncologist 2005;10:92–103

    Abstract/FREE Full Text
18. ↵
    DePrimo SE, Bello C. Surrogate biomarkers in evaluating response to antiangiogenic agents: focus on sunitinib. Ann Oncol 2007;18 (suppl 10):x11–19

    Abstract/FREE Full Text
19. ↵
    Miles KA. Perfusion CT for the assessment of tumour vascularity: which protocol? Br J Radiol 2003;76 (spec no 1):S36–42

    Abstract/FREE Full Text
20. ↵
    Jemal A, Siegel R, Ward E, et al. Cancer Statistics, 2007. CA Cancer J Clin 2007;57:43–66

    CrossRefPubMedWeb of Science
21. ↵
    Harnsberger H, Hudgins P, Wiggins R, et al. Diagnostic Imaging. Head and Neck. Salt Lake City: Hamirsys;2004
22. ↵
    Sanelli PC, Nicola G, Johnson R, et al. Effect of training and experience on qualitative and quantitative CT perfusion data. AJNR Am J Neuroradiol 2007;28:428–32

    Abstract/FREE Full Text
23. ↵
    Goh V, Halligan S, Hugill JA, et al. Quantitative colorectal cancer perfusion measurement using dynamic contrast-enhanced multidetector-row computed tomography: effect of acquisition time and implications for protocols. J Comput Assist Tomogr 2005;29:59–63

    CrossRefPubMed
24. ↵
    Kalra MK, Small WC, Torres WE. A 45-second CT perfusion protocol for rectal cancers may not be adequate to infer vascular permeability-surface area products. Radiology 2006;238:755–56

    CrossRefPubMed
25. ↵
    Goh V, Halligan S, Gartner L, et al. Quantitative colorectal cancer perfusion measurement by multidetector-row CT: does greater tumour coverage improve measurement reproducibility? Br J Radiol 2006;79:578–83

    Abstract/FREE Full Text
26. ↵
    Sahani DV, Holalkere NS, Mueller PR, et al. Advanced hepatocellular carcinoma: CT perfusion of liver and tumor tissue—initial experience. Radiology 2007;243:736–43

    CrossRefPubMedWeb of Science